Tectonic Therapeutic | AVRO - Zinsaufwendungen Für Schuld

Aktienkurs
30.00
Täglich Wechseln
-0.83 -2.69%
Monatlich
41.58%
Jährlich
41.84%
Q1 Prognose
32.30




Zinsaufwendungen Für Schuld Veränderung Datum
Akebia Therapeutics 4.83M 359.32M 2025-12
Alnylam Pharmaceuticals USD 129.34M 84.94M 2025-12
Celltrion KRW 19B 1.96B 2025-06
Cspc Pharmaceutical CNY 10.19M 4.73M 2025-09
Deva Holding AS TRY 272.53M 69.04M 2023-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 30M 2025-12
Gilead Sciences USD 255M 1000K 2025-12
Ionis Pharmaceuticals USD 18M 0 2025-12
Kangmei Pharma CNY 1.82M 150K 2025-09
Karyopharm Therapeutics USD 11.38M 2.43M 2024-09
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Laboratorios Farma EUR 699K 666.2K 2025-06
MacroGenics USD 3.34M 2.54M 2025-09
Medical Developments International AUD 18K 3K 2025-06
Neuren Pharmaceuticals AUD 0 0 2024-06
Organigram Holdings CAD 179K 127K 2025-03
Ovoca Bio EUR 7K 6K 2022-06
Pfizer USD 711M 59M 2025-12
Pharma Mar EUR 117K 1.24M 2025-09
Qiagen NV USD 10.14M 1.92M 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Sanofi EUR -25M 252M 2025-12
Sarepta Therapeutics USD 7.56M 2.33M 2025-09
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Takeda JPY 123.63B 40.49B 2025-12
Tilray USD 6.7M 2.73M 2025-06
Zealand Pharma A/S 7.07M 74K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06